Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain.
Saved in:
| Title: | Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain. |
|---|---|
| Authors: | Gavelli, Francesco1,2 (AUTHOR) francesco.gavelli@uniupo.it, Giolitti, Francesca Maria2 (AUTHOR), Vidali, Matteo1,3 (AUTHOR), Montersino, Marta1,4 (AUTHOR), Bertoli, Matteo1,5 (AUTHOR), Molinari, Luca1,2,6 (AUTHOR), Baldrighi, Marco1,2 (AUTHOR), Beltrame, Michela1,2 (AUTHOR), Sainaghi, Pier Paolo1,3,4 (AUTHOR), Bellan, Mattia1,2,4 (AUTHOR), Patrucco, Filippo1,5 (AUTHOR), Avanzi, Gian Carlo1,2,6 (AUTHOR), Castello, Luigi Mario1,6 (AUTHOR) |
| Source: | Diagnostics (2075-4418). Nov2025, Vol. 15 Issue 22, p2851. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20754418 |
|---|---|
| DOI: | 10.3390/diagnostics15222851 |
